Emergence of functional spinal delta opioid receptors after chronic ethanol exposure

Richard M van Rijn1, Daniela I Brissett, Jennifer L Whistler

  • 1Ernest Gallo Clinic and Research Center, Department of Neurology, University of California San Francisco, Emeryville, California 94608, USA.

Biological Psychiatry
|September 6, 2011
PubMed
Abstract

Insights

Chronic ethanol exposure upregulates delta opioid receptors (DORs) in spinal cord thermal pain circuits. This suggests DORs are a novel therapeutic target for conditions involving receptor redistribution.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Research

Background:

  • Delta opioid receptors (DORs) are promising targets for alcoholism, anxiety, and pain.
  • DORs are often underappreciated due to low expression in naive states.
  • Chronic stress, opioids, or inflammation can increase cell surface DORs.

Purpose of the Study:

  • To investigate the effect of chronic ethanol exposure on DOR expression and function in spinal cord pain circuits.
  • To determine if DORs are involved in thermal or mechanical pain pathways after ethanol exposure.

Main Methods:

  • Administered DOR and mu opioid receptor (MOR) agonists and antagonists spinally in mice.
  • Assessed thermal antinociception (tail-flick assay) and mechanical sensitivity (von Frey filaments).
  • Utilized wild-type and DOR/MOR knockout mice, with and without chronic ethanol exposure.

Main Results:

  • Prolonged ethanol exposure upregulated functional DORs in spinal thermal pain circuits.
  • No DOR upregulation was observed in mechanical sensitivity circuits.
  • Upregulated DORs may modulate MOR-mediated analgesia via circuit convergence or form heteromeric units with MORs.

Conclusions:

  • Ethanol-induced DOR redistribution in thermal pain pathways suggests a novel therapeutic strategy.
  • DORs represent a potential target for conditions characterized by receptor redistribution.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...